Schedule 13D ownership disclosure

Odonate Therapeutics, Inc.

Security class unavailable · CUSIP: 676079106

Event date: 2021-11-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,958,577
Percent of class
33.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-21-012098
Form type
SC 13D/A
Filer
Odonate Therapeutics, Inc.
CIK
CIK 1717452
Filed
Nov 19, 2021
Reporting period
Nov 17, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub